Tannenbaum, Stacey

Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

Kuemmerle-Deschner, J. B., Ramos, E., Blank, N., Roesler, J., Felix, S. D., Jung, T., Stricker, K., Chakraborty, A., Tannenbaum, S., Wright, A. M., et al. (2011) · Arthritis Research & Therapy

Inflammasome and immune disordersAutoimmune and Inflammatory Disorders Research

Cited by 121

Guidelines for the Quality Control of Population Pharmacokinetic–Pharmacodynamic Analyses: an Industry Perspective

Bonate, P. L., Strougo, A., Desai, A., Roy, M., Yassen, A., van der Walt, J. S., Kaibara, A., & Tannenbaum, S. (2012) · The AAPS Journal

Pharmaceutical studies and practicesStatistical Methods in Clinical Trials

Cited by 39